the decrease in early stage dollars... I wonder if this is because there are less early stage deals, or that the value of each early deal has gotten lower.

Thanks for posting. Interesting stats.

Yea... the numbers are pretty interesting. I wonder if the figures are just US based or for VCs across the globe. I figure the bio tech industry will keep getting more and more of the VC attention as the green wave rolls on.